Advertisement

PETA Buys Chimp Lab Stock

The animal rights organization purchases shares of a research facility in a bid to end chimpanzee testing at the facility.

By | December 22, 2011

Tanzanian chimpanzeeFLICKR, NILS RINALDI

People for the Ethical Treatment of Animals (PETA) has purchased stock of a Maryland-based private research facility BIOQUAL, which conducts tests on great apes. The animal rights organization plans to raise a resolution at the next shareholder’s meeting to end testing on chimpanzees, according to a press release from the organization.

BIOQUAL is currently testing a heptatitis C vaccine, and recently conducted research in the great apes using norovirus, which causes diarrhea, according to a press release. The action comes in the wake of last week’s Institute of Medicine report, which halted all new federal funding for chimpanzee research and found that most studies do not need to use the animals. The report’s writers were divided as to whether hepatitis C vaccine research should be allowed.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Advertisement

Popular Now

  1. Antibiotics and the Gut Microbiome
  2. Sex Differences in Pain Pathway
  3. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  4. Anti-Vax Doctor Found Dead
    The Nutshell Anti-Vax Doctor Found Dead

    Police are calling the death of James Bradstreet, a physician who claimed vaccines cause autism and offered autism cures to patients, an apparent suicide.

Advertisement
Shimadzu Scientific
Shimadzu Scientific
Advertisement
The Scientist